Back to Investors

Madison International Realty

Evidence PackPRODeal PackIndependent
Real EstateNEW YORK, NY, US Website
AUM
$6B
Ownership
independent
Stakeability
61 / MEDIUM
Priority
Tier
Employees
25

Global real estate private equity firm specializing in recapitalizations and equity investments. $10B+ AUM.

SEC RegisteredFund PerformanceBDC ExposureTeam DataILS DealsRegulatory

Coverage

50%

Adaptive profile: standard

Signals present
6/12
SEC / ADVFund Performance(21)BDC Exposure(20)13F Holders(0)Team(30)ILS Deals(1)Regulatory(25)Legal(0)Lobbying(0)Hiring(0)News(0)GP Stakes Deals(0)

Data Freshness

Recent Changes

Stakeability Breakdown

61 / 100
Fund PerformanceAUM growth and fundraising track record
75
Team StabilityLeadership continuity and key person risk
71
Market PositionBrand strength and competitive positioning
61
Succession ReadinessNext-gen leadership and governance structure
80
Transaction FeasibilityLikelihood of a stake transaction
66
Unable to load signal breakdown.

IC Risk Memo

PRO

Investment committee-ready memo with risk analysis and recommendation

Click "Generate Memo" to create an IC-ready analysis

Includes risk factors, citations, and recommendation

CRD Number
158165
SEC File Number
801-73977
Registration Type
Registered
Filing Date
Apr 10, 2025
Employee Count
N/A
Discretionary AUM
$6.1B
Private Funds
25
PE Funds
N/A
VC Funds
N/A
RE Funds
25
Hedge Funds
N/A
Gross Assets (Private)
$4.0B
Source: SEC IAPD

Fund performance data requires Professional

Upgrade your plan to access this section.

Upgrade

BDC exposure data requires Professional

Upgrade your plan to access this section.

Upgrade

Team data requires Professional

Upgrade your plan to access this section.

Upgrade

Team intelligence requires Professional

Upgrade your plan to access this section.

Upgrade

Competition mapping requires Professional

Upgrade your plan to access this section.

Upgrade

Regulatory data requires Professional

Upgrade your plan to access this section.

Upgrade

No GP stakes deals recorded

This GP has not sold a minority stake, making it a potential target.